# FDA recall D-0717-2021

> **Med Shop Total Care Inc.** · Class I · drug recall initiated 2020-10-05.

## Product

HYDROMORPHONE HCL-BUPIVACAINE HCL PF INJECTABLE 21 and 22 mL syringes in various strengths: a) 0.5MG-5MG/ML, b) 2MG-35MG/ML, c) 25MG-15MG/ML, d) 6MG-1.5MG/ML, e) 3MG-3MG/ML, f) 5MG-15MG/ML, g)12MG-8MG/ML, h)2MG-2MG/ML, i) 30MG-30MG/ML, j) 8MG-20MG/ML, k) 20MG-10MG/ML, l)50MG-3.5MG/ML, m) 10MG-30MG/ML, n)15MG-1.6MG/ML, o) 20MG-30MG/ML, p)15MG-6MG/ML, q)15MG-27MG/ML, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605

## Reason for recall

Non-Sterility

## Distribution

Texas and Puerto Rico

## Key facts

- **Recall number:** D-0717-2021
- **Recalling firm:** Med Shop Total Care Inc.
- **Classification:** Class I
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-10-05
- **Report date:** 2021-08-18
- **Termination date:** 2023-08-17

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Longview, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0717-2021

## Citation

> AI Analytics. FDA recall D-0717-2021. Retrieved 2026-06-26 from https://api.ai-analytics.org/recall/D-0717-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*